Sanofi, Zealand hit by U.S. setback for diabetes drug

Employee walks into an office of French drugmaker Sanofi in ShanghaiPARIS (Reuters) – French drugmaker Sanofi said on Thursday it would withdraw its U.S. application for diabetes treatment lixisenatide in order to wait for results from an ongoing cardiovascular patient study. The decision, which will delay the drug's launch in the world's biggest market, sent shares in Sanofi down 1.6 percent by 0720 GMT, while its smaller Danish partner Zealand Pharma dropped 20 percent. …

China drugmaker Sino Biopharmaceutical investigating TV corruption report

By Adam Jourdan SHANGHAI (Reuters) – Chinese drug company Sino Biopharmaceutical Ltd has set up a team to investigate allegations broadcast on state television that its majority-owned subsidiary had paid for illegal overseas trips for doctors, it said on Thursday. Regional sales teams at Chia Tai Tianqing Pharmaceutical Group Co Ltd, 60 percent owned by Sino Biopharmaceutical, had paid for doctors to travel to Thailand and Taiwan, which could be considered illegal bribes, China Central Television (CCTV) reported late on Wednesday. …

1 74 75 76 77 78 99